Screener
Jazz Pharmaceuticals JAZZ Raw materials
Raw materials at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryRawMaterialsNetOfReserves.
The source filing: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:09 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001232524-26-000025
FAQ
- What is Jazz Pharmaceuticals's raw materials?
- Jazz Pharmaceuticals (JAZZ) reported raw materials of $27.6M in Q1 2026.
- How has Jazz Pharmaceuticals's raw materials changed year-over-year?
- Jazz Pharmaceuticals's raw materials decreased by 17.6% year-over-year, from $33.48M to $27.6M.
- What is the long-term trend for Jazz Pharmaceuticals's raw materials?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's raw materials has grown at a 6.6% compound annual growth rate (CAGR), from $16M to $22M.
- What does raw materials mean?
- Unprocessed materials and components purchased for use in manufacturing, valued at cost.
Ask your AI about Jazz Pharmaceuticals's raw materials.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude